New Perspectives and Open Issues in the Adjuvant and Neoadjuvant Treatment of Melanoma. [PDF]
Spagnoletti A +14 more
europepmc +1 more source
Immune Checkpoint Inhibitors in Malignant Melanoma: Anti-PD-1, Anti-CTLA-4 and Anti-LAG-3 Therapies. [PDF]
Allen-Tejerina AM +4 more
europepmc +1 more source
First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort trial. [PDF]
Lorenzen S +20 more
europepmc +1 more source
Case Report: triple therapy with pembrolizumab, ipilimumab, and lenvatinib in mitotane- and radiation-refractory, cortisol-secreting stage IV adrenocortical carcinoma: a genomically guided approach. [PDF]
Nakhleh A +5 more
europepmc +1 more source
Lichen Planopilaris Induced by Checkpoint Inhibitors: A Systematic Review
International Journal of Dermatology, Volume 65, Issue 6, Page 1263-1265, June 2026.
Niyoosha Yoosefi +2 more
wiley +1 more source
Advanced Mucosal Melanoma Therapies: Current Status and Future Directions. [PDF]
Zhang Y, Zhao D, Wu D.
europepmc +1 more source
Dural-based melanoma metastasis mimicking a posterior fossa meningioma: A case report and review of the literature. [PDF]
Raffa PEAZ +9 more
europepmc +1 more source
Immunotherapy and Stereotactic Body Radiation Treatment-An Overview of the Current Landscape of the Strategic Combination of Two Treatment Modalities to Achieve Better Therapeutic Outcomes. [PDF]
Abraham A +4 more
europepmc +1 more source
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0. [PDF]
McKay RR +18 more
europepmc +1 more source

